Potential Research Applications: IGF-1 receptor binding affinity and cellular signaling studies Cellular growth and differentiation pathway research Binding protein resistance and in vitro stability mechanism models Growth factor analog activity and structure-function investigations For laboratory research only
This metabolic penalty persists for years and makes maintaining weight loss without pharmacological support extraordinarily difficult
Wen J, Nadora D, Bernstein E, et al
Fujiwara, Y., Eguchi, S., Murayama, H., Takahashi, Y., Toda, M., Imai, K., & Tsuda, K
Within 5 years post-surgery, WR rates can range from 37% to 76% among patients undergoing gastric bypass [13] and sleeve gastrectomy [14, 15], respectively
Retatrutide (LY3437943) is a novel triple-acting peptide agonist developed by Eli Lilly